Live Breaking News & Updates on Failed Targeted

Stay updated with breaking news from Failed targeted. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Actinium Pharma Highlights Three Abstracts Accepted for Poster Presentation at the SOHO 2023 Annual Meeting

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today. ....

United States , Astellas Pharma , Matthew Beck , Actinium Pharmaceuticals Inc , Investor Relations Communications , Exchange Commission , Actimaba National Cancer Institute , Oncology Lg Chem Life Sciences , Society Of Hematologic Oncology , Actinium Pharmaceuticals , Hematologic Oncology , Randomized Phase , Elderly Relapsed , Patients With Active , Failed Targeted , Grand Ballroom , Deep Responses , Prolonged Survival , Adverse Risk Acute Myeloid Leukemia , Received Prior Venetoclax , Antileukemic Activity , Preclinical Model , National Cancer Institute , Life Sciences , Pharmaceuticals , Health Care Amp Hospitals ,